|
2024
|
G/S
|
House mark for pharmaceutical and medical preparations for the treatment of oncology, autoimmune,... |
|
|
Invention
|
Stat3 degraders and uses thereof.
The present invention relates to STAT3 degraders, their liquid... |
|
|
Invention
|
Irak4 degraders and uses thereof. The present invention provides compounds, compositions thereof,... |
|
|
Invention
|
Stat degraders and uses thereof.
The present invention provides compounds, compositions thereof,... |
|
|
Invention
|
Irak degraders and uses thereof.
The present invention provides compounds, compositions thereof,... |
|
|
Invention
|
Irak degraders and uses thereof. The present invention provides compounds, compositions thereof, ... |
|
|
Invention
|
Stat3 degraders and uses thereof. The present invention relates to STAT3 degraders, their liquid ... |
|
|
Invention
|
Tyk2 degraders and uses thereof. The present invention provides compounds, compositions thereof, ... |
|
|
Invention
|
Mdm2 degraders and uses thereof. The present invention provides compounds, compositions thereof, ... |
|
|
Invention
|
Solid forms of mdm2 degraders. The present disclosure relates generally to various solid forms an... |
|
|
Invention
|
Deuterated mdm2 degraders and uses thereof. The present invention provides deuterium-enriched com... |
|
|
Invention
|
Mdm2 degraders and uses thereof. The present invention relates to compositions useful for the mod... |
|
|
Invention
|
Irak4 degraders and uses thereof. The present invention relates to IRAKIMiD degraders, their liqu... |
|
|
Invention
|
Crbn ligands and uses thereof.
The present invention provides compounds, compositions thereof, a... |
|
|
Invention
|
Tricyclic crbn ligands and uses thereof.
The present invention provides compounds, compositions ... |
|
|
Invention
|
Stat3 degraders and uses thereof. The present invention provides compounds, compositions thereof,... |
|
|
Invention
|
Mk2 degraders and uses thereof. The present invention provides compounds, compositions thereof, a... |
|
2023
|
Invention
|
Irak4 degraders and uses thereof. The present invention provides IRAK4 degraders, formulations an... |
|
|
Invention
|
Methods of treating mutant lymphomas.
The present invention relates to methods of treating MYD88... |
|
|
Invention
|
Protein degraders and uses thereof. The present invention provides compounds, compositions thereo... |
|
|
Invention
|
Salt forms of irak4 degraders.
The present disclosure relates generally to various salt forms an... |
|
|
Invention
|
Salt forms of irak4 degraders. The present disclosure relates generally to various salt forms and... |
|
|
Invention
|
Stat6 degraders and uses thereof. The present invention provides compounds, compositions thereof,... |
|
|
Invention
|
Irak4 degraders and uses thereof.
The present invention relates to a method of treating autoimmu... |
|
|
Invention
|
Cdk2 inhibitors and uses thereof.
The present invention provides compounds, compositions thereof... |
|
|
Invention
|
Cdk2 degraders and uses thereof.
The present invention provides compounds, compositions thereof,... |
|
|
Invention
|
Cdk2 degraders and uses thereof. The present invention provides compounds, compositions thereof, ... |
|
|
Invention
|
Cdk2 inhibitors and uses thereof. The present invention provides bicyclic and monocyclic heterocy... |
|
|
Invention
|
Deuterated stat3 degraders and uses thereof. The present invention provides deuterium-enriched co... |
|
|
Invention
|
Stat degraders and uses thereof. The present invention provides compounds, compositions thereof, ... |
|
|
Invention
|
Mdm2 degraders and uses thereof. The present invention relates to MDM2 degraders, their liquid fo... |
|
|
Invention
|
Smarca degraders and uses thereof. The present invention provides compounds degrading one or more... |
|
|
Invention
|
Crystalline forms of irak degraders.
The present disclosure relates generally to various forms, ... |
|
2022
|
Invention
|
Tyk2 degraders and uses thereof.
The present invention provides compounds, compositions thereof,... |
|
|
Invention
|
Mdm2 degraders and uses thereof.
The present invention provides compounds, compositions thereof,... |
|
|
G/S
|
Pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncolog... |
|
|
G/S
|
Pharmaceutical and medical preparations for the treatment of
oncology, autoimmune, immune-oncolo... |
|
|
Invention
|
Deuterated irak degraders and uses thereof.
The present application provides novel bifunctional ... |
|
|
Invention
|
Smarca degraders and uses thereof.
The present invention provides compounds, compositions thereo... |
|
|
G/S
|
Pharmaceutical and medical preparations for the treatment of cancer, immune inflammatory diseases... |
|
2021
|
Invention
|
Double degraders and uses thereof.
The present invention provides compounds, compositions thereo... |
|
|
G/S
|
Pharmaceutical research and development; drug development and discovery services; medical and sci... |
|
|
Invention
|
Mdm2 degraders and uses thereof.
The present invention relates to compounds and methods useful f... |
|
2020
|
G/S
|
Research and development of therapeutic drugs for the treatment of
oncology, autoimmune, immune-o... |
|
2019
|
G/S
|
Pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune oncolog... |
|
|
G/S
|
Research and development of therapeutic drugs for the treatment of oncology, autoimmune, immune-o... |
